ANTICUERPOS DE P-CADERINA
La presente invención se refiere a anticuerpos y a porciones de unión a antígeno de los mismos que se unen a P-caderina. The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MELANIE BOYLE TODD LEE VANARSDALE RICHARD DAVID HEAD RICHARD ALLEN MAZZARELLA RALPH RAYMOND MINTER MAUREEN JERI BOURNER BARRETT RICHARD THIELE DAVID WILLIAM GRIGGS GERALD FRIES CASPERSON CRISTOPHER TODD BAUER WILLIAM DEAN JOY MARK ALLEN MOFFAT |
| description | La presente invención se refiere a anticuerpos y a porciones de unión a antígeno de los mismos que se unen a P-caderina.
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HN2006015949A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HN2006015949A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HN2006015949A3</originalsourceid><addsrcrecordid>eNrjZJB09AvxdA51DQrwD1ZwcVUI0HV2dHEN8vRz5GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8R5-RgYGZgaGppYmlo7GRCkCAECwID4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICUERPOS DE P-CADERINA</title><source>esp@cenet</source><creator>MELANIE BOYLE ; TODD LEE VANARSDALE ; RICHARD DAVID HEAD ; RICHARD ALLEN MAZZARELLA ; RALPH RAYMOND MINTER ; MAUREEN JERI BOURNER ; BARRETT RICHARD THIELE ; DAVID WILLIAM GRIGGS ; GERALD FRIES CASPERSON ; CRISTOPHER TODD BAUER ; WILLIAM DEAN JOY ; MARK ALLEN MOFFAT</creator><creatorcontrib>MELANIE BOYLE ; TODD LEE VANARSDALE ; RICHARD DAVID HEAD ; RICHARD ALLEN MAZZARELLA ; RALPH RAYMOND MINTER ; MAUREEN JERI BOURNER ; BARRETT RICHARD THIELE ; DAVID WILLIAM GRIGGS ; GERALD FRIES CASPERSON ; CRISTOPHER TODD BAUER ; WILLIAM DEAN JOY ; MARK ALLEN MOFFAT</creatorcontrib><description>La presente invención se refiere a anticuerpos y a porciones de unión a antígeno de los mismos que se unen a P-caderina.
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.</description><language>spa</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110117&DB=EPODOC&CC=HN&NR=2006015949A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110117&DB=EPODOC&CC=HN&NR=2006015949A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MELANIE BOYLE</creatorcontrib><creatorcontrib>TODD LEE VANARSDALE</creatorcontrib><creatorcontrib>RICHARD DAVID HEAD</creatorcontrib><creatorcontrib>RICHARD ALLEN MAZZARELLA</creatorcontrib><creatorcontrib>RALPH RAYMOND MINTER</creatorcontrib><creatorcontrib>MAUREEN JERI BOURNER</creatorcontrib><creatorcontrib>BARRETT RICHARD THIELE</creatorcontrib><creatorcontrib>DAVID WILLIAM GRIGGS</creatorcontrib><creatorcontrib>GERALD FRIES CASPERSON</creatorcontrib><creatorcontrib>CRISTOPHER TODD BAUER</creatorcontrib><creatorcontrib>WILLIAM DEAN JOY</creatorcontrib><creatorcontrib>MARK ALLEN MOFFAT</creatorcontrib><title>ANTICUERPOS DE P-CADERINA</title><description>La presente invención se refiere a anticuerpos y a porciones de unión a antígeno de los mismos que se unen a P-caderina.
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB09AvxdA51DQrwD1ZwcVUI0HV2dHEN8vRz5GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8R5-RgYGZgaGppYmlo7GRCkCAECwID4</recordid><startdate>20110117</startdate><enddate>20110117</enddate><creator>MELANIE BOYLE</creator><creator>TODD LEE VANARSDALE</creator><creator>RICHARD DAVID HEAD</creator><creator>RICHARD ALLEN MAZZARELLA</creator><creator>RALPH RAYMOND MINTER</creator><creator>MAUREEN JERI BOURNER</creator><creator>BARRETT RICHARD THIELE</creator><creator>DAVID WILLIAM GRIGGS</creator><creator>GERALD FRIES CASPERSON</creator><creator>CRISTOPHER TODD BAUER</creator><creator>WILLIAM DEAN JOY</creator><creator>MARK ALLEN MOFFAT</creator><scope>EVB</scope></search><sort><creationdate>20110117</creationdate><title>ANTICUERPOS DE P-CADERINA</title><author>MELANIE BOYLE ; TODD LEE VANARSDALE ; RICHARD DAVID HEAD ; RICHARD ALLEN MAZZARELLA ; RALPH RAYMOND MINTER ; MAUREEN JERI BOURNER ; BARRETT RICHARD THIELE ; DAVID WILLIAM GRIGGS ; GERALD FRIES CASPERSON ; CRISTOPHER TODD BAUER ; WILLIAM DEAN JOY ; MARK ALLEN MOFFAT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HN2006015949A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>MELANIE BOYLE</creatorcontrib><creatorcontrib>TODD LEE VANARSDALE</creatorcontrib><creatorcontrib>RICHARD DAVID HEAD</creatorcontrib><creatorcontrib>RICHARD ALLEN MAZZARELLA</creatorcontrib><creatorcontrib>RALPH RAYMOND MINTER</creatorcontrib><creatorcontrib>MAUREEN JERI BOURNER</creatorcontrib><creatorcontrib>BARRETT RICHARD THIELE</creatorcontrib><creatorcontrib>DAVID WILLIAM GRIGGS</creatorcontrib><creatorcontrib>GERALD FRIES CASPERSON</creatorcontrib><creatorcontrib>CRISTOPHER TODD BAUER</creatorcontrib><creatorcontrib>WILLIAM DEAN JOY</creatorcontrib><creatorcontrib>MARK ALLEN MOFFAT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MELANIE BOYLE</au><au>TODD LEE VANARSDALE</au><au>RICHARD DAVID HEAD</au><au>RICHARD ALLEN MAZZARELLA</au><au>RALPH RAYMOND MINTER</au><au>MAUREEN JERI BOURNER</au><au>BARRETT RICHARD THIELE</au><au>DAVID WILLIAM GRIGGS</au><au>GERALD FRIES CASPERSON</au><au>CRISTOPHER TODD BAUER</au><au>WILLIAM DEAN JOY</au><au>MARK ALLEN MOFFAT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICUERPOS DE P-CADERINA</title><date>2011-01-17</date><risdate>2011</risdate><abstract>La presente invención se refiere a anticuerpos y a porciones de unión a antígeno de los mismos que se unen a P-caderina.
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_HN2006015949A |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | ANTICUERPOS DE P-CADERINA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T02%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MELANIE%20BOYLE&rft.date=2011-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHN2006015949A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |